Track topics on Twitter Track topics that are important to you
Phone: 41 (0)31 631 2508
Fax: 41 (0)31 631 2635
Penn Medicine researchers may have found the reason why some patients with advanced chronic lymphocytic leukemia don't respond to chimeric antigen receptor T cell therapy, and the answer is tied to ho...
(University of Pennsylvania School of Medicine) Penn Medicine researchers may have found the reason why some patients with advanced chronic lymphocytic leukemia (CLL) don't respond to chimeric antigen...
The University of Texas MD Anderson Cancer Center and Berkeley Lights said today they have launched a new biopharma focused on developing cancer cell therapies discovered at MD Anderson, and manufactu...
In this episode of PharmaTelevision News Review, filmed at BioEurope Spring 2013, in Barcelona, Spain, Fintan Walton talks to Gary Rabin, CEO of Advanced Cell Technology
Treatment-naïve patients with advanced clear-cell renal cell carcinoma had significantly longer progression-free survival when treated with pazopanib instead of temsirolimus.
The approval of the nivolumab and ipilimumab combination provides a new first-line treatment option for a segment of patients with advanced renal cell carcinoma. News Alerts
International Stem Cell (OTCQB:ISCO) a California-based clinical stage biotechnology company developing novel stem cell-based therapies and biomedical products, announced today that the Company plans ...
'World First' centres will develop and deliver systems for the delivery of cutting edge cell and gene therapies
BIO-CORNEUM HC Advanced Scar Supervision Anti-Itch Gel
Shiseido Advanced Hydro-Liquid Compact Foundation
Cell-based therapy is emerging as a promising strategy for treating a wide range of human diseases, such as diabetes, blood disorders, acute liver failure, spinal cord injury, and several types of can...
Managing increasingly prevalent chronic diseases will require close continuous monitoring of patients. Cell-based biosensors may be used for implantable diagnostic systems to monitor health status. Ce...
Two studies in this issue of Cell Systems use the Gini index from economics to benchmark and quantify gene expression heterogeneity in single-cell or bulk RNA-seq datasets.
Microfluidic systems have been developed for patterning single cells to study cell-cell interactions. However, patterning multiple types of cells to understand heterogeneous cell-cell interactions rem...
Rationale: Pancreatic adenocarcinoma is a malignancy with a poor prognosis. Resection is the only curative option and still 5-year survival rate is less than 10 percent. However, most pati...
The purpose of the study is to compare the clinical benefit, as measured by duration of overall survival, of Nivolumab vs. Everolimus in subjects with advanced or metastatic clear-cell ren...
The proposed clinical trial is a phase I, open-label, multi-center, dose-escalation study of ALT-803 in patients with surgically incurable advanced solid tumors: melanoma, renal cell, non-...
The clinical outcome of advanced / metastatic renal cell carcinoma has been changed since targeted therapy being widely applied. This study will retrospectively analyse the clinical outcom...
The purpose of the study is to test different doses of X4P-001 given alone and in combination with axitinib in patients diagnosed with advanced renal cell carcinoma. The goals of the study...
CELLnTEC's expertise with the development of epithelial progenitor cell culture systems is also available thorugh a selection of unique services.
One Cell Systems is developing and marketing a family of single cell assays that rely on microencapsulation and flow cytometry. Technology underlying these products has been developed internally and l...
ADVANCED CELL & GENE THERAPY, LLC, is a consulting firm serving biotechnology companies, clinical laboratories, and biotechnology investors. We provide practical, experienced guidance in development, ...
Biological Industries (www.bioind.com) is one of the worldâs leading and trusted suppliers to the life sciences industry, with over 35 yearsâ experience in cell culture ...
Advanced Cell Technology, Inc. is a biotechnology company applying cellular technology in the field of regenerative medicine. For more information, visit http://www.advancedcell.c...
We have published hundreds of CELLnTEC Advanced Cell Systems news stories on BioPortfolio along with dozens of CELLnTEC Advanced Cell Systems Clinical Trials and PubMed Articles about CELLnTEC Advanced Cell Systems for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of CELLnTEC Advanced Cell Systems Companies in our database. You can also find out about relevant CELLnTEC Advanced Cell Systems Drugs and Medications on this site too.